The Geoffrey Beene Cancer Research Center provides support for the Geoffrey Beene Translational Oncology Core Facility, the Microchemistry and Proteomics Core Facility, the Genomics Core Facility, and the High-Throughput Drug Screening Core Facility.
Geoffrey Beene Translational Oncology Core Facility
Directed by Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program within Memorial Hospital, the Geoffrey Beene Translational Oncology Core was established in 2007 to take full advantage of the wealth of clinical samples and the emerging information issuing from Memorial Sloan-Kettering Cancer Center clinical trials by applying state-of-the art genome-scale molecular profiling technologies.
Microchemistry and Proteomics Core Facility
The Microchemistry and Proteomics Core focuses on transcriptional regulation and ties together molecular, developmental, and cellular science.
Genomics Core Facility
The Genomics Core is the Microarray Core Facility of Memorial Sloan-Kettering Cancer Center. Its specialty is the processing of very small samples for the Affymetrix array.
High-Throughput Drug Screening Core Facility
The mission of the High-Throughput Drug Screening Core Facility is to provide investigators with access to cost-effective high-throughput screening of both small molecules (Chemical Scanning) and RNAi (Gene Scanning) libraries. The Core features modern robotics and custom-built screening data management databases for storing and querying data obtained from screening.